Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-02

Clinical Trial Update: A Study of Enfuvirtide (Fuzeon) in Patients With Advanced Human Immunodeficiency Virus-1 (HIV-1) Infection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for enfuvirtide (Fuzeon) in patients with advanced HIV-1 infection; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fuzeon (enfuvirtide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: HIV Infections | Phase 4 | Status: COMPLETED